Raymond James Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.4M Buy
362,721
+72,190
+25% +$4.92M 0.01% 1320
2026
Q1
$18.7M Buy
290,531
+7,597
+3% +$536K 0.01% 1521
2025
Q4
$19.1M Buy
282,934
+1,487
+0.5% +$100K 0.01% 1479
2025
Q3
$20.6M Buy
281,447
+29,046
+12% +$1.93M 0.01% 1391
2025
Q2
$13.1M Sell
252,401
-54,378
-18% -$3.09M ﹤0.01% 1672
2025
Q1
$19.6M Sell
306,779
-149,995
-33% -$8.71M 0.01% 1326
2024
Q4
$21.8M Buy
+456,774
New +$23.4M 0.01% 1237

Other funds holding HALO

Raymond James Financial's HALO Position: Q2 2026 in Review

Raymond James Financial increased its Halozyme (HALO) stake by 25% in Q2 2026, buying an estimated $4.92M and bringing the position to 362,721 shares worth $28.4M. The position accounts for 0.01% of the portfolio, ranked #1320.

Raymond James Financial first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Raymond James Financial held 362,721 shares of Halozyme worth $28.4M as of Q2 2026.
  • Raymond James Financial bought 72,190 Halozyme shares in Q2 2026, an estimated $4.92M.
  • Halozyme made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1320 holding.
  • Raymond James Financial first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.